atorvastatin has been researched along with Colonic Neoplasms in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 9 (69.23) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, H; Li, Z; Zheng, N; Zhi, Y | 1 |
| Li, F; Qiu, P; Song, M; Wang, M; Wang, Q; Wu, X; Xiao, H; Xu, F; Zheng, J | 1 |
| Brewer, M; Janakiram, NB; Mohammed, A; Rao, CV; Steele, VE; Vedala, K | 1 |
| Correia, A; Hirvonen, J; Li, W; Liu, D; Mäkilä, E; Salonen, J; Santos, HA; Zhang, H | 1 |
| Cai, X; Gao, Z; Li, F; Qiu, P; Rakariyatham, K; Song, M; Wang, M; Wu, X; Xiao, H; Xu, F; Zheng, J | 1 |
| Jin, H; Koo, PT; Tsang, DJ; Xiao, H; Yang, CS; Yang, Z | 1 |
| Carpentino, JE; Eaton, K; Higgins, PD; Huang, EH; Hynes, MJ; Johnson, LA | 1 |
| DeCastro, A; Janakiram, NB; Lee, HJ; Paul, S; Rao, CV; Reddy, BS; Simi, B; Smolarek, AK; So, JY; Steele, V; Suh, N; Wang, CX | 1 |
| Casto, BC; Knobloch, TJ; Lubet, RA; Pereira, MA; Steele, VE; Warner, BM; Weghorst, CM | 1 |
| Guan, F; Ju, J; Li, G; Liu, AB; Sun, Y; Yang, CS; Yang, Z | 1 |
| Hiramatsu, N; Mamo, JC; Pal, S; Takechi, R | 1 |
| Khor, TO; Kong, AN; Kopelovich, L; Rao, CV; Reddy, BS; Steele, VE; Wang, CX; Zheng, X | 1 |
| Lin, Y; Reddy, BS; Xiao, H; Yang, CS; Zhang, Q | 1 |
13 other study(ies) available for atorvastatin and Colonic Neoplasms
| Article | Year |
|---|---|
Synergistic Effect of Tangeretin and Atorvastatin for Colon Cancer Combination Therapy: Targeted Delivery of These Dual Drugs Using RGD Peptide Decorated Nanocarriers.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Atorvastatin; Cell Line; Cell Proliferation; Cell Survival; Colonic Neoplasms; Drug Carriers; Drug Delivery Systems; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Female; Flavones; Humans; Kinetics; Ligands; Mice; Mice, Inbred BALB C; Molecular Structure; Nanoparticles; Neoplasms, Experimental; Oligopeptides; Particle Size | 2020 |
A metabolite of nobiletin, 4'-demethylnobiletin and atorvastatin synergistically inhibits human colon cancer cell growth by inducing G0/G1 cell cycle arrest and apoptosis.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Atorvastatin; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Drug Synergism; Flavones; G1 Phase Cell Cycle Checkpoints; HT29 Cells; Humans; Molecular Structure; Rats; Rats, Inbred F344 | 2018 |
Multitargeted low-dose GLAD combination chemoprevention: a novel and promising approach to combat colon carcinogenesis.
Topics: Adenomatous Polyps; Animals; Antineoplastic Combined Chemotherapy Protocols; Atorvastatin; Carcinogenesis; Cell Proliferation; Chemoprevention; Colon; Colonic Neoplasms; Cytokines; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Eflornithine; Female; Gefitinib; Heptanoic Acids; Intestine, Small; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Molecular Targeted Therapy; Pyrroles; Quinazolines | 2013 |
Microfluidic assembly of a nano-in-micro dual drug delivery platform composed of halloysite nanotubes and a pH-responsive polymer for colon cancer therapy.
Topics: Aluminum Silicates; Atorvastatin; Caco-2 Cells; Celecoxib; Cell Death; Cell Proliferation; Cell Survival; Clay; Colonic Neoplasms; Drug Delivery Systems; Drug Liberation; HT29 Cells; Humans; Hydrogen-Ion Concentration; Microfluidics; Microspheres; Nanotubes; Permeability; Polymers | 2017 |
Synergistic chemopreventive effects of nobiletin and atorvastatin on colon carcinogenesis.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Atorvastatin; Azoxymethane; Carcinogenesis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Chemoprevention; Colon; Colonic Neoplasms; Drug Synergism; Drug Therapy, Combination; Flavones; HT29 Cells; Humans; Male; Mice; Rats; Rats, Inbred F344 | 2017 |
Synergistic actions of atorvastatin with gamma-tocotrienol and celecoxib against human colon cancer HT29 and HCT116 cells.
Topics: Atorvastatin; Celecoxib; Cell Cycle; Cell Division; Cell Line, Tumor; Chromans; Colonic Neoplasms; Cyclooxygenase 2 Inhibitors; Drug Synergism; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mevalonic Acid; Polyisoprenyl Phosphates; Pyrazoles; Pyrroles; Sulfonamides; Vitamin E | 2010 |
Atorvastatin induces apoptosis in vitro and slows growth of tumor xenografts but not polyp formation in MIN mice.
Topics: Animals; Apoptosis; Atorvastatin; Colonic Neoplasms; Colonic Polyps; Disease Models, Animal; DNA Fragmentation; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoblotting; In Situ Nick-End Labeling; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Mice, Nude; Pyrroles; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2010 |
Combination of atorvastatin with sulindac or naproxen profoundly inhibits colonic adenocarcinomas by suppressing the p65/β-catenin/cyclin D1 signaling pathway in rats.
Topics: Adenocarcinoma; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Antineoplastic Combined Chemotherapy Protocols; Atorvastatin; Azoxymethane; beta Catenin; Carcinogens; Colonic Neoplasms; Cyclin D1; eIF-2 Kinase; Enzyme-Linked Immunosorbent Assay; Heptanoic Acids; Immunoenzyme Techniques; Interleukin-4; Male; Naproxen; Nitric Oxide Synthase Type II; Pyrroles; Rats; Rats, Inbred F344; Signal Transduction; Sulindac; Tumor Necrosis Factor-alpha | 2011 |
Chemoprevention of mouse lung and colon tumors by suberoylanilide hydroxamic acid and atorvastatin.
Topics: Animals; Atorvastatin; Colonic Neoplasms; Dimethylhydrazines; Female; Heptanoic Acids; Histone Deacetylase Inhibitors; Hydroxamic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lung Neoplasms; Mice; Nitrosamines; Pyrroles; RNA, Messenger; Urethane; Vorinostat | 2012 |
Deleterious effects of high concentrations of (-)-epigallocatechin-3-gallate and atorvastatin in mice with colon inflammation.
Topics: Animals; Atorvastatin; Azoxymethane; Catechin; Colitis; Colon; Colonic Neoplasms; Dextran Sulfate; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Gastrointestinal Hemorrhage; Heptanoic Acids; Leukotriene B4; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Pyrroles; Rectum; Weight Loss | 2012 |
Red wine polyphenolics suppress the secretion and the synthesis of Apo B48 from human intestinal CaCo-2 cells.
Topics: Apolipoprotein B-48; Apolipoproteins B; Atorvastatin; Cell Line, Tumor; Colonic Neoplasms; Flavonoids; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Phenols; Polyphenols; Pyrroles; Wine | 2004 |
Prevention of azoxymethane-induced colon cancer by combination of low doses of atorvastatin, aspirin, and celecoxib in F 344 rats.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Aspirin; Atorvastatin; Azoxymethane; Carcinogens; Celecoxib; Cell Growth Processes; Colonic Neoplasms; Dose-Response Relationship, Drug; Heptanoic Acids; Male; Pyrazoles; Pyrroles; Rats; Rats, Inbred F344; Sulfonamides | 2006 |
Combination of atorvastatin and celecoxib synergistically induces cell cycle arrest and apoptosis in colon cancer cells.
Topics: Apoptosis; Atorvastatin; Celecoxib; Cell Cycle; Cell Survival; Colonic Neoplasms; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; G1 Phase; GTP-Binding Proteins; HCT116 Cells; Heptanoic Acids; HT29 Cells; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoblotting; MAP Kinase Kinase 4; Proto-Oncogene Proteins c-akt; Pyrazoles; Pyrroles; Resting Phase, Cell Cycle; Signal Transduction; Sulfonamides; Time Factors | 2008 |